Inventor
CHALBERG JR THOMAS W
US19 patents
⚠️ This page may combine multiple inventors who share the name “CHALBERG JR THOMAS W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGHTGLASS VISION INC
7 patentsUS10884264B2Jan 5, 2021
Ophthalmic lenses with light scattering for treating myopia
SIGHTGLASS VISION INC58 citations95
US11914228B2Feb 27, 2024
Ophthalmic lenses with light scattering for treating myopia
SIGHTGLASS VISION INC5 citations83
US12111518B2Oct 8, 2024
Ophthalmic lenses with dynamic optical properties for reducing development of myopia
SIGHTGLASS VISION INC2 citations71
US11718052B2Aug 8, 2023
Contact lenses for reducing myopia and methods for making the same
SIGHTGLASS VISION INC2 citations71
US12468175B2Nov 11, 2025
Ophthalmic lenses with light scattering for treating myopia
SIGHTGLASS VISION INC0 citations60
US12416818B2Sep 16, 2025
Ophthalmic lenses for reducing myopic progression and methods of making the same
SIGHTGLASS VISION INC0 citations51
US12092905B2Sep 17, 2024
Methods and devices for reducing myopia in children
SIGHTGLASS VISION INC0 citations40
WAVESHIFT LLC
4 patentsUS11221501B2Jan 11, 2022
Using binocular rivalry for expanding color perception
WAVESHIFT LLC4 citations71
US11205398B2Dec 21, 2021
Evaluating and reducing myopiagenic effects of electronic displays
WAVESHIFT LLC2 citations70
US11892714B2Feb 6, 2024
Using binocular rivalry for expanding color perception
WAVESHIFT LLC1 citations60
US10621948B2Apr 14, 2020
Evaluating and reducing myopiagenic effects of electronic displays
WAVESHIFT LLC1 citations59
ADVERUM BIOTECHNOLOGIES INC
3 patentsUS11021519B2Jun 1, 2021
Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
ADVERUM BIOTECHNOLOGIES INC16 citations85
US11248214B2Feb 15, 2022
Compositions and methods for enhanced gene expression in cone cells
ADVERUM BIOTECHNOLOGIES INC2 citations72
US12275959B2Apr 15, 2025
Compositions and methods for enhanced gene expression in cone cells
ADVERUM BIOTECHNOLOGIES INC0 citations62